Adrenergic control of a constitutively active acetylcholine-regulated potassium current in canine atrial cardiomyocytes

Cardiovascular Research

Volumn 74, Issue 3, 2007, Pages 406-415

  Yeh, Yung Hsin ^a,b   Ehrlich, Joachim R ^c   Qi, Xiaoyan ^a   Hébert, Terence E ^d   Chartier, Denis ^a   Nattel, Stanley ^a,d  

^a MONTREAL HEART INSTITUTE   (Canada)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c GOETHE UNIVERSITY   (Germany)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Ion channels; Second messengers; Signal transduction

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; 8 BROMO CYCLIC AMP; ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BISINDOLYLMALEIMIDE; CHLOROETHYLCLONIDINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FORSKOLIN; ISOPRENALINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NIGULDIPINE; PHENYLEPHRINE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; POTASSIUM ION; PRAZOSIN; PROPRANOLOL;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CHOLINERGIC SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DOG; FEMALE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; MALE; MICROELECTRODE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; REGULATORY MECHANISM; SUPRAVENTRICULAR TACHYCARDIA; WHOLE CELL;

ACETYLCHOLINE; ACTION POTENTIALS; ADRENERGIC AGENTS; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BEE VENOMS; CLONIDINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIHYDROPYRIDINES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRENES; HEART ATRIA; IMIDAZOLES; INDOLES; ISOPROTERENOL; ISOQUINOLINES; MALEIMIDES; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PHENYLEPHRINE; PHORBOL 12,13-DIBUTYRATE; PHOSPHOLIPASE C; PIPERAZINES; POTASSIUM CHANNELS; PRAZOSIN; PROPANOLAMINES; PROPRANOLOL; PROTEIN KINASE C; PYRROLIDINONES; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-1; SULFONAMIDES;

EID: 34247855175     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.01.020     Document Type: Article

References (53)

1. Ehrlich J.R., Cha T.-J., Zhang L., Chartier D., Villeneuve L., Hébert T.E., et al. Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium. J Physiol 557 (2004) 583-597
2. Cha T.J., Ehrlich J.R., Chartier D., Xiao L., and Nattel S. Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias. Circulation 113 (2006) 1730-1737
3. K,ACh is constitutively active in patients with chronic atrial fibrillation. Circulation 112 (2005) 3697-3706
4. Conrath C.E., and Opthof T. Ventricular repolarization: an overview of (patho)physiology, sympathetic effects and genetic aspects. Prog Biophys Mol Biol 92 (2006) 269-307
5. Zicha S., Tsuji Y., Shiroshita-Takeshita A., and Nattel S. Beta-blockers as antiarrhythmic agents. Handb Exp Pharmacol 171 (2006) 235-266
6. Norris R.M., Barnaby P.F., Brown M.A., Geary G.G., Clarke E.D., Logan R.L., et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet 2 (1984) 883-886
7. Coumel P. Cardiac arrhythmias and the autonomic nervous system. J Cardiovasc Electrophysiol 4 (1993) 338-355
8. Penn R.B., Parent J.L., Pronin A.N., Panettieri Jr. R.A., and Benovic J.L. Pharmacological inhibition of protein kinases in intact cells: antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitations of usefulness. J Pharmacol Exp Ther 288 (1999) 428-437
9. Tsien R.W., Giles W., and Greengard P. Cyclic AMP mediates the effects of adrenaline on cardiac Purkinje fibres. Nat New Biol 240 (1972) 181-183
10. Chen L., Kurokawa J., and Kass R.S. Phosphorylation of the A-kinase-anchoring protein Yotiao contributes to protein kinase A regulation of a heart potassium channel. J Biol Chem 280 (2005) 31347-31352
11. Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A.R., et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295 (2002) 496-499
12. + current in human atrial myocytes. Circ Res 78 (1996) 903-915
13. Koumi S., Backer C.L., Arentzen C.E., and Sato R. beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts. J Clin Invest 96 (1995) 2870-2881
14. + current in guinea-pig ventricular myocytes. J Physiol 486 (1995) 647-659
15. Fedida D., Shimoni Y., and Giles W.R. Alpha-adrenergic modulation of the transient outward current in rabbit atrial myocytes. J Physiol 423 (1990) 257-277
16. Tohse N., Nakaya H., Hattori Y., Endou M., and Kanno M. Inhibitory effect mediated by alpha 1-adrenoceptors on transient outward current in isolated rat ventricular cells. Pflugers Arch 415 (1990) 575-581
17. + current in rabbit ventricular myocytes. J Physiol 441 (1991) 673-684
18. Braun A.P., Fedida D., and Giles W.R. Activation of alpha 1-adrenoceptors modulates the inwardly rectifying potassium currents of mammalian atrial myocytes. Pflugers Arch 421 (1992) 431-439
19. + current of guinea pig ventricular cells through the activation of protein kinase C. Circ Res 71 (1992) 1441-1446
20. Yue L., Feng J., Wang Z., and Nattel S. Adrenergic control of the ultrarapid delayed rectifier current in canine atrial myocytes. J Physiol 516.2 (1999) 385-398
21. Mullner C., Vorobiov D., Bera A.K., Uezono Y., Yakubovich D., Frohnwieser-Steinecker B., et al. Heterologous facilitation of G protein-activated K(+) channels by beta-adrenergic stimulation via cAMP-dependent protein kinase. J Gen Physiol 115 (2000) 547-558
22. + channels in a receptor-specific manner. Proc Natl Acad Sci U S A 102 (2005) 4643-4648
23. + channel is mediated by arachidonic acid metabolites. Pflugers Arch 414 (1989) 102-104
24. Roy M.L., and Sontheimer H. Beta-adrenergic modulation of glial inwardly rectifying potassium channels. J Neurochem 64 (1995) 1576-1584
25. + channel via cyclic AMP-dependent protein kinase in atrial cells. Circ Res 67 (1990) 1292-1298
26. Medina I., Krapivinsky G., Arnold S., Kovoor P., Krapivinsky L., and Clapham D.E. A switch mechanism for G beta gamma activation of I(KACh). J Biol Chem 275 (2000) 29709-29716
27. Mullner C., Yakubovich D., Dessauer C.W., Platzer D., and Schreibmayer W. Single channel analysis of the regulation of GIRK1/GIRK4 channels by protein phosphorylation. Biophys J 84 2 Pt 1 (2003) 1399-1409
28. + current desensitization. Nat Cell Biol 2 (2000) 507-514
29. + current in atrial myocytes. J Biol Chem 276 (2001) 5650-5658
30. + channel, GIRK, in Xenopus oocytes. J Gen Physiol 109 (1997) 477-490
31. + channels expressed in Xenopus oocytes through a protein kinase C-dependent pathway. Mol Pharmacol 55 (1999) 1020-1027
32. + channel by a Ca(2+)-independent protein kinase C. J Physiol 534 (2001) 367-379
33. Nikolov E.N., and Ivanova-Nikolova T.T. Coordination of membrane excitability through a GIRK1 signaling complex in the atria. J Biol Chem 279 (2004) 23630-23636
34. + channels by intracellular acidosis. J Biol Chem 278 (2003) 7091-7098
35. + channels by protein kinase C. Proc Natl Acad Sci U S A 101 (2004) 1087-1092
36. Lavine N., Ethier N., Oak J.N., Pei L., Liu F., Trieu P., et al. G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase. J Biol Chem 277 (2002) 46010-46019
37. Rebois R.V., Robitaille M., Gales C., Dupre D.J., Baragli A., Trieu P., et al. Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells. J Cell Sci 119 (2006) 2807-2818
38. Rebois R.V., and Hebert T.E. Protein complexes involved in heptahelical receptor-mediated signal transduction. Receptors Channels 9 (2003) 169-194
39. Lei Q., Talley E.M., and Bayliss D.A. Receptor-mediated inhibition of G protein-coupled inwardly rectifying potassium channels involves G(alpha)q family subunits, phospholipase C, and a readily diffusible messenger. J Biol Chem 276 (2001) 16720-16730
40. Zhang L., Lee J.K., John S.A., Uozumi N., and Kodama I. Mechanosensitivity of GIRK channels is mediated by protein kinase C-dependent channel-phosphatidylinositol 4,5-bisphosphate interaction. J Biol Chem 279 (2004) 7037-7047
41. van Tiel C.M., Westerman J., Paasman M., Wirtz K.W., and Snoek G.T. The protein kinase C-dependent phosphorylation of serine 166 is controlled by the phospholipid species bound to the phosphatidylinositol transfer protein alpha. J Biol Chem 275 (2000) 21532-21538
42. Burashnikov A., and Antzelevitch C. Differences in the electrophysiologic response of four canine ventricular cell types to alpha 1-adrenergic agonists. Cardiovasc Res 43 (1999) 901-908
43. Dirksen R.T., and Sheu S.S. Modulation of ventricular action potential by alpha 1-adrenoceptors and protein kinase. C. Am J Physiol 258 (1990) H907-H911
44. Fedida D., Braun A.P., and Giles W.R. Alpha 1-adrenoceptors in myocardium: functional aspects and transmembrane signaling mechanisms. Physiol Rev 73 (1993) 469-487
45. Heidbuchel H., Vereecke J., and Carmeliet E. The electrophysiological effects of acetylcholine in single human atrial cells. J Mol Cell Cardiol 19 (1987) 1207-1219
46. Heidbuchel H., Callewaert G., Vereecke J., and Carmeliet E. Membrane-bound nucleoside diphosphate kinase activity in atrial cells of frog, guinea pig, and human. Circ Res 71 (1992) 808-820
47. Singh B.N. Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview. J Cardiovasc Pharmacol Ther 10 Suppl 1 (2005) S3-S14
48. Goldman S., Olajos M., and Morkin E. Cholinergic-sympathetic interactions in the left atrium and left ventricle of conscious dogs. J Pharmacol Exp Ther 225 (1983) 219-223
49. Priori S.G., Napolitano C., and Schwartz P.J. Cardiac receptor activation and arrhythmogenesis. Eur Heart J 14 Suppl E (1993) 20-26
50. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266 (1991) 15771-15781
51. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351 (2000) 95-105
52. Glass D.B., Cheng H.C., Mende-Mueller L., Reed J., and Walsh D.A. Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J Biol Chem 264 (1989) 8802-8810
53. KACh in acetylcholine-induced atrioventricular blocks. Br J Pharmacol 131 (2000) 569-577